AAAAAA

   
Results: 1-25 | 26-50 | 51-69
Results: 1-25/69

Authors: PLATONOV AE SHIPULIN GA VERSHININA IV DANKERT J VANDEWINKEL JGJ KUIJPER EJ
Citation: Ae. Platonov et al., ASSOCIATION OF HUMAN FC-GAMMA-RIIA (CD32) POLYMORPHISM WITH SUSCEPTIBILITY TO AND SEVERITY OF MENINGOCOCCAL DISEASE, Clinical infectious diseases, 27(4), 1998, pp. 746-750

Authors: VIDARSSON G VANDEWINKEL JGJ
Citation: G. Vidarsson et Jgj. Vandewinkel, RECEPTOR AND COMPLEMENT RECEPTOR-MEDIATED PHAGOCYTOSIS IN HOST-DEFENSE, Current opinion in infectious diseases, 11(3), 1998, pp. 271-278

Authors: VANDERPOL WL VANDEWINKEL JGJ
Citation: Wl. Vanderpol et Jgj. Vandewinkel, IGG RECEPTOR POLYMORPHISMS - RISK-FACTORS FOR DISEASE, Immunogenetics (New York), 48(3), 1998, pp. 222-232

Authors: DEVRIES IJM WALKER C VANREIJSEN FC DUBOIS GR KNOL EF BRUIJNZEELKOOMEN CAFM VANDEWINKEL JGJ BRUIJNZEEL PLB
Citation: Ijm. Devries et al., INDUCTION AND FUNCTION OF FC-GAMMA-RI ON HUMAN EOSINOPHILS - LIGATIONOF FC-GAMMA-RI ON EOSINOPHILS RESULTS IN ACCESSORY SIGNALS FOR CD3-INDUCED T-LYMPHOCYTE PROLIFERATION, Journal of allergy and clinical immunology, 101(1), 1998, pp. 612-612

Authors: HAZENBOS WLW HEIJNEN IAFM MEYER D HOFHUIS FMA DELAVALETTE CR SCHMIDT RE CAPEL PJA VANDEWINKEL JGJ GESSNER JE VANDENBERG TK VERBEEK JS
Citation: Wlw. Hazenbos et al., MURINE IGG1 COMPLEXES TRIGGER IMMUNE EFFECTOR FUNCTIONS PREDOMINANTLYVIA FC-GAMMA-RIII (CD16), The Journal of immunology (1950), 161(6), 1998, pp. 3026-3032

Authors: PAPAPANOU PN NEIDERUD AM PAPADIMITRIOU A SANDROS J MADIANOS PN VANDEWINKEL JGJ DAHLEN G
Citation: Pn. Papapanou et al., A MULTI-FACTORIAL MODEL FOR ASSESSING THE RISK FOR PERIODONTAL-DISEASE, Journal of dental research, 77, 1998, pp. 124-124

Authors: VANVUGT MJ VANDENHERIKOUDIJK IE VANDEWINKEL JGJ
Citation: Mj. Vanvugt et al., FC-GAMMA-RIA-GAMMA-CHAIN COMPLEXES TRIGGER ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY (ADCC) IN CD5(-CELL() B)MACROPHAGE-IIA1.6 CELLS/, Clinical and experimental immunology, 113(3), 1998, pp. 415-422

Authors: PLATONOV AE KUIJPER EJ VERSHININA IV SHIPULIN GA WESTERDAAL N FIJEN CAP VANDEWINKEL JGJ
Citation: Ae. Platonov et al., MENINGOCOCCAL DISEASE AND POLYMORPHISM OF FC-GAMMA-RIIA (CD32) IN LATE COMPLEMENT COMPONENT-DEFICIENT INDIVIDUALS, Clinical and experimental immunology, 111(1), 1998, pp. 97-101

Authors: WURFLEIN D DECHANT M STOCKMEYER B TUTT AL HU PS REPP R KALDEN JR VANDEWINKEL JGJ EPSTEIN AL VALERIUS T GLENNIE M GRAMATZKI M
Citation: D. Wurflein et al., EVALUATING ANTIBODIES FOR THEIR CAPACITY TO INDUCE CELL-MEDIATED LYSIS OF MALIGNANT B-CELLS, Cancer research, 58(14), 1998, pp. 3051-3058

Authors: STOCKMEYER B DECHANT M REPP R VALERIUS T DEO Y GRAZIANO R KALDEN JR GLENNIE M VANDEWINKEL JGJ GRAMATZKI W
Citation: B. Stockmeyer et al., IMMUNOTHERAPY OF B-CELL MALIGNANCIES VIA [FC-ALPHA-RIXCD20] DIRECTED BISPECIFIC ANTIBODIES, British Journal of Haematology, 102(1), 1998, pp. 85-85

Authors: CARLSSON LE SANTOSO S BAURICHTER G KROLL H PAPENBERG S EICHLER P WESTERDAAL NAC KIEFEL V VANDEWINKEL JGJ GREINACHER A
Citation: Le. Carlsson et al., HEPARIN-INDUCED THROMBOCYTOPENIA - NEW INSIGHTS INTO THE IMPACT OF THE FC-GAMMA-RIIA-R-H131 POLYMORPHISM, Blood, 92(5), 1998, pp. 1526-1531

Authors: MANGER K REPP R SPRIEWALD BM RASCU A GEIGER A WASSMUTH R WESTERDAAL NAC WENTZ B MANGER B KALDEN JR VANDEWINKEL JGJ
Citation: K. Manger et al., FC-GAMMA RECEPTOR IIA POLYMORPHISM IN CAUCASIAN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - ASSOCIATION WITH CLINICAL SYMPTOMS, Arthritis and rheumatism, 41(7), 1998, pp. 1181-1189

Authors: VALERIUS T ELSASSER D REPP R VANDEWINKEL JGJ GRAMATZKI M GLENNIE M
Citation: T. Valerius et al., HLA CLASS-II ANTIBODIES RECRUIT G-CSF ACTIVATED NEUTROPHILS FOR TREATMENT OF B-CELL MALIGNANCIES, Leukemia & lymphoma, 26(3-4), 1997, pp. 261

Authors: VERBEEK JS HAZENBOS WLW CAPEL PJA VANDEWINKEL JGJ
Citation: Js. Verbeek et al., THE ROLE OF FCR IN IMMUNITY - LESSONS FROM GENE TARGETING IN MICE, Research in immunology, 148(7), 1997, pp. 466-474

Authors: DEGAST GC VANDEWINKEL JGJ BAST BEJEG
Citation: Gc. Degast et al., CLINICAL PERSPECTIVES OF BISPECIFIC ANTIBODIES IN CANCER, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 121-123

Authors: HEIJNEN IAFM GLENNIE MJ VANDEWINKEL JGJ
Citation: Iafm. Heijnen et al., LYSIS OF MURINE B-LYMPHOMA-CELLS BY TRANSGENIC PHAGOCYTES VIA A HUMANFC-GAMMA-RI X MURINE MHC CLASS-II BISPECIFIC ANTIBODY, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 166-170

Authors: VANOJIK HH REPP R GROENEWEGEN G VALERIUS T VANDEWINKEL JGJ
Citation: Hh. Vanojik et al., CLINICAL-EVALUATION OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-FC-GAMMA-RI-X-ANTI-HER-2 NEU) IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR (FILGRASTIM) FOR TREATMENT OF ADVANCED BREAST-CANCER/, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 207-209

Authors: STOCKMEYER B VALERIUS T REPP R DEO Y VANSPIEK A KALDEN JR VANDEWINKEL JGJ GRAMATZKI M
Citation: B. Stockmeyer et al., FC-ALPHA-RI (CD89) AS A NOVEL CYTOTOXIC TRIGGER MOLECULE FOR BISPECIFIC ANTIBODIES, Experimental hematology, 25(8), 1997, pp. 560-560

Authors: POOLE A GIBBINS JM TURNER M VANVUGT MJ VANDEWINKEL JGJ SAITO T TYBULEWICZ VLJ WATSON SP
Citation: A. Poole et al., THE FC RECEPTOR GAMMA-CHAIN AND THE TYROSINE KINASE SYK ARE ESSENTIALFOR ACTIVATION OF MOUSE PLATELETS BY COLLAGEN, EMBO journal, 16(9), 1997, pp. 2333-2341

Authors: GRATAMA JW VANDERLINDEN R VANDERHOLT B BOLHUIS RLH VANDEWINKEL JGJ
Citation: Jw. Gratama et al., ANALYSIS OF FACTORS CONTRIBUTING TO THE FORMATION OF MONONUCLEAR CELLAGGREGATES (ESCAPEES) IN FLOW CYTOMETRIC IMMUNOPHENOTYPING, Cytometry, 29(3), 1997, pp. 250-260

Authors: DEO YM GRAZIANO RF REPP R VANDEWINKEL JGJ
Citation: Ym. Deo et al., CLINICAL-SIGNIFICANCE OF IGG FC-RECEPTORS AND FC-GAMMA-R-DIRECTED IMMUNOTHERAPIES, Immunology today, 18(3), 1997, pp. 127-135

Authors: VANDEWINKEL JGJ BAST B DEGAST GC
Citation: Jgj. Vandewinkel et al., IMMUNOTHERAPEUTIC POTENTIAL OF BISPECIFIC ANTIBODIES, Immunology today, 18(12), 1997, pp. 562-564

Authors: HEIJNEN IAFM RIJKS LJM SCHIEL A STOCKMEYER B VANOJIK HH DECHANT M VALERIUS T KELER T TUTT AL GLENNIE MJ VANROYEN EA CAPEL PJA VANDEWINKEL JGJ
Citation: Iafm. Heijnen et al., GENERATION OF HER-2 NEU-SPECIFIC CYTOTOXIC NEUTROPHILS IN-VIVO - EFFICIENT ARMING OF NEUTROPHILS BY COMBINED ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND FC-GAMMA RECEPTOR-I BISPECIFIC ANTIBODIES/, The Journal of immunology, 159(11), 1997, pp. 5629-5639

Authors: KOBAYASHI T WESTERDAAL NAC SUZUKI T VANDERPOL WL MIYAZAKI A YOSHIE H VANDEWINKEL JGJ HARA K
Citation: T. Kobayashi et al., IGG FC RECEPTOR POLYMORPHISM IN RECURRENT PERIODONTAL-DISEASE, Journal of dental research, 76, 1997, pp. 144-144

Authors: KOBAYASHI T WESTERDAAL NAC MIYAZAKI A VANDERPOL WL SUZUKI T YOSHIE H VANDEWINKEL JGJ HARA K
Citation: T. Kobayashi et al., RELEVANCE OF IMMUNOGLOBULIN-G FC RECEPTOR POLYMORPHISM TO RECURRENCE OF ADULT PERIODONTITIS IN JAPANESE PATIENTS, Infection and immunity, 65(9), 1997, pp. 3556-3560
Risultati: 1-25 | 26-50 | 51-69